ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000446.1|Tilivalline_1 # 3 # 83 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.506	BGC0000446.1|Tilivalline_1 	3	83	+	Loose	2070	20.0162	smeE	31.58	3003056	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TCCTCTGACTGGACTCGAACCAGTGACATACGGATTAACAGTCCGCCGTTCTACCGACTGAACTACAGAGGAATCGTGTGA	SSDWTRTSDIRINSPPFYRLNYRGIV	MARFFIDRPIFAWVIAIIIMLAGGLALFKLPVSMYPNVAPPAVEISATYPGASAKVVEDSVTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQEVQRQGINVAKSSSGFLNAIAFVSENGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGGKYAMRIWLDPNKLHTYGLSVPEVTAAIKAQNAQVAIGQLGGAPSVKGQQLNATINAQSRLQTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANALDTAAGVDAALEDMKGFFPAGLKAEIPYDTTPFVRVSIKGVVQTLIEAIVLVFVVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAMLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMALSVLVAIVLTPALCATMLKPLKKGEHHVAHRGLAGRFFNGFNRGFDRTSESYQRGVRGIIHRPWRFMGIVAALFVLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESIAALENHFLQNEKDAVDSVFSVQGFSFAGMGQNAGMAFVKLKDWSERDADNGVMPITGRAMAALGQIKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAGSKKLANVRPNGQEDTPQFRIDIDAAKATSLGLSIDQINGTLAAAWGSSYIDDFVDRGRVKRVFVQADQAFRMVPEDFDLWSVKNDKGEMVPFSAFATKHWDYGSPRLERYNGVSAMEIQGEPAPGVASGDAMAEIEQLAKQLPAGFGIEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAAMYESWSVPTAVLLAAPLGILGAVLANTFKGLERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGASLIESIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGVFFVPLFFVVVQRVFKRRSTT	2.50	gnl|BL_ORD_ID|807|hsp_num:0	876			966	1023	tetracycline; chloramphenicol
BGC0000446.1|Tilivalline_2 # 375 # 1322 # 1 # ID=1_2;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.584	BGC0000446.1|Tilivalline_2 	375	1322	+	Loose	500	51.2174	leuO	24.57	3003843	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGGTACTGGTGTTCCTTACAGGAGGCAAAATGAACTTAAGACGACTGAAGTATTTCGTAAAAATCGTCGATATCGGCAGTCTGACCCAGGCCGCTGAAGTCTTGCACATCGCACAACCGGCGCTGAGCCAGCAGGTTGCGACCCTGGAAGGCGAGCTGGACCAGCAGTTGTTGATTCGCACCAAACGCGGCGTCACGCCGACCGAAGCGGGCAAGATCTTGTATACCCACGCCCGTACTATTCTGCGCCAGTGCGAGCAGGCGCAGCTGGCGGTAAATAATGTCGGTCAAACGCTAAGTGGCCAGGTATCGATTGGCCTGGCGCCTGGCACGGCGGCTTCGGCCATCACTATGCCGCTGCTGCAAACGGTGCGTAACGAGCTGCCGGAAGTGATGGTCTATCTCCAGGAAAGTAGCGGAACCCTCCTCAACGATAAGCTTATCGACGGTCAGCTGGATATGGCCGTACTTTATGAACGTTCCCCGGTTGCCGGGATCATCAGCCAGCCGCTGCTAAAAGAAGATCTCTACCTGGTCGGTACCCGGGATTGTCCGGGGCAGAGCGTGGATCTGACGGCGGTCGCGGAGATGAATCTGTTCTTGCCGCGCGATTACAGCGCCGTTCGCGCAAGGGTGACCGAAGCCTTCACCCTGCGTCGCTTATCGGCCAAAATTATCGGTGAAATTGAATCCATTACCACCCTGACGGCAGCCATTGCCAGCGGCATGGGCGTCACCGTTCTGCCGGAGTCCGCCGCCCGTTCGTTGTGCAGCGCGGCCAACGGCTGGATGGCGCGCATCAGCACGCCGTCAATGAGCCTGTCGCTGTCGCTCAATATGTCGGCTCGCGGCAGTCTGTCGCCGCAGGCGCAGGCGGTGAAGGAGATCCTGATGTCGCTGGTGAGTCGCCCGTCGCTGGAGAATCGTGAATTACAGTTAGTCAGTTGA	MVLVFLTGGKMNLRRLKYFVKIVDIGSLTQAAEVLHIAQPALSQQVATLEGELDQQLLIRTKRGVTPTEAGKILYTHARTILRQCEQAQLAVNNVGQTLSGQVSIGLAPGTAASAITMPLLQTVRNELPEVMVYLQESSGTLLNDKLIDGQLDMAVLYERSPVAGIISQPLLKEDLYLVGTRDCPGQSVDLTAVAEMNLFLPRDYSAVRARVTEAFTLRRLSAKIIGEIESITTLTAAIASGMGVTVLPESAARSLCSAANGWMARISTPSMSLSLSLNMSARGSLSPQAQAVKEILMSLVSRPSLENRELQLVS	MPEVQTDHPETAELSKPQLRMVDLNLLTVFDAVMQEQNITRAAHALGMSQPAVSNAVARLKVMFNDELFVRYGRGIQPTARAFQLFGSVRQALQLVQNELPGSGFEPASSERVFHLCVCSPLDSILTSQIYNHIEQIAPNIHVMFKSSLNQNTEHQLRYQETEFVISYEDFHRPEFTSVPLFKDEMVLVASKNHPTIKGPLLKHDVYNEQHAAVSLDRFASFSQTWYDTVDKQASIAYQGMAMMSVLSVVSQTHLVAIAPRWLAEEFAESLELQVLPLPLKQNSRTCYLSWHEAAGRDKGHQWMEEQLVSICKR	100.32	gnl|BL_ORD_ID|4926|hsp_num:0	5921			63	585	acriflavine; puromycin
BGC0000446.1|Tilivalline_3 # 1405 # 2379 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.561	BGC0000446.1|Tilivalline_3 	1405	2379	+	Loose	550	44.669	NmcR	35.85	3003665	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NmcA beta-lactamase	ATGTCTGATAGCCCGGAGGAAAGGGTGAACTTCCAGCAGCTCAAAATTATTCGTGAAGCGGCCCGTCAGGATTACAACCTGACGGAAGTCGCCAATATGCTCTATACATCGCAGTCGGGCGTTAGCCGCCATATTCGTGAACTGGAAGAAGAGCTGGGGATCGAGATTTTTATCCGCCGCGGCAAACGTCTGCTGGGGATGACCGAGCCGGGCAAAGCGTTGCTGTCGATTGCCGAGCGTATCCTCAATGAAGCCAGCAACGTTCGTCGCCTGGCGGACCTGTTTACCAACGATGCCTCCGGCGTCTTAACCATCGCCACTACGCATACCCAGGCGCGCTATAGTCTGCCGCCGGTGATTAAAGCCTTCCGTGAACTCTTTTCTGATGTCCGTCTTGAACTGGTGCAGGGAACGCCGCAGGAAATTGAAACGCTGCTGCATAACGGCGGCGCGGATATTGGTATCGCCAGCGAGCGTCTGAGCAACGATCCGACGCTGGTGGCTTTTCCCTGGTTCCGCTGGCACCACAGTCTGCTGGTTCCCAAAGATCATCCTCTGACCCAGGTGACGCCGTTGACCCTTGAGGCGATTGCCCGTTGGCCGCTCATCACCTATCGCCAGGGCATAACCGGCCGTTCACGCATCGATGAAGCCTTTAACCGTAAAGGGTTGATGCCGGATATCGTATTGAGCGCACAGGACTCAGACGTCATCAAAACCTACGTTGAGCTGGGGCTGGGCGTGGGGCTGGTGGCGGAACAGTCGGGAGATGAGCGGGAGTCTGATACCTTTACGCGTCTTGATACCCGCCATCTGTTCGATGCCAATACCGTCTGGCTGGGCCTGAAGCGCGGACAGCTGCAGCGAAATTACGTCTGGCGTTTTATTGAACTCTGTAATGCAGGCCTGTCGCTGGAGGAGATTAAACGCCAGGCGATGGAGCCGGAAGAGGCGGCGATCGATTATCAAATTTAG	MSDSPEERVNFQQLKIIREAARQDYNLTEVANMLYTSQSGVSRHIRELEEELGIEIFIRRGKRLLGMTEPGKALLSIAERILNEASNVRRLADLFTNDASGVLTIATTHTQARYSLPPVIKAFRELFSDVRLELVQGTPQEIETLLHNGGADIGIASERLSNDPTLVAFPWFRWHHSLLVPKDHPLTQVTPLTLEAIARWPLITYRQGITGRSRIDEAFNRKGLMPDIVLSAQDSDVIKTYVELGLGVGLVAEQSGDERESDTFTRLDTRHLFDANTVWLGLKRGQLQRNYVWRFIELCNAGLSLEEIKRQAMEPEEAAIDYQI	MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQLTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENPWIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPSDLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQKELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS	109.83	gnl|BL_ORD_ID|1905|hsp_num:0	2072			39	345	cefoxitin; cefazolin; ampicillin
BGC0000446.1|Tilivalline_4 # 2416 # 3327 # -1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.598	BGC0000446.1|Tilivalline_4 	2416	3327	-	Loose	500	25.0238	cmrA	31.25	3002702	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGCCCGGCGCGATTCACATCAACGCCCTCGCCCTTCACAAAAGCCTGCATCGCCGGCGTGACGGGAAGCGGTACCTTGCGGTCCGATTCATACTCCGCGCGGTTTCGCGACAGCGGCTCATGAACTTCAACCCAGCGGCTACCGTCCGGCTCGGCGGTATATTTCACCGGCTGATCGATAATCTGCACCCGCGTGCCTACCGGAACGGTATCAAACAGGTACTTGATGTCGTCATTGCGCAAGCGAATGCAGCCCTGGCTCACCCGCAGGCCAATGCCGAAATTGGCGTTGGTGCCATGAATGGCGTACAGCCTGCCGATATAAATGGCGTACAGTCCCATCGGGTTATCCGGCCCGGCCGGCACAAATGCCGGCAGACTTTCGCCCCGGCTGGCATATTCCCGGCGAGTATTGGCGGTTGGCGTCCAGGTTGGCGCCTCCTGCTTACGCTCAACGGCGGTCACCCAGTTACGCGGGGTTTCGCGCCCTGCCTGGCCAATACCAATCGGCAGAACCTCGACCGTTGTGCCTTCAGGCGGATAGTAGTAAAGGCGCATTTCAGCAACGTTGATCACAATGCCGTTGCGAACCGTGGCGGGCAGGATAAGCTGCTGCGGCACCACCAGCGTGGTGCCCGATTTCGGCAGGAACACATCGACGCCCGGGTTGGCCTCCAGCATATTGCTCAGGCCCTGGCCGTACTGAGCGGCAAAGGCCTCAAGCGGCTGGGTATTGTTCTGCGGAATCGTGATGGTCAACGGGCTGCCTACCAGACGGCTTCCTTCCGGCGGCAGCGGGTAGCTCACCGCCAGAGCGCTCTGGCTGGTGAGAAGCATAATAAAAGAACAAAGCAGTTTCACGCGCCGCACAATTTCCCTTCCTCTGTGGCGATTATCGTGAATGAATTATAG	MPGAIHINALALHKSLHRRRDGKRYLAVRFILRAVSRQRLMNFNPAATVRLGGIFHRLIDNLHPRAYRNGIKQVLDVVIAQANAALAHPQANAEIGVGAMNGVQPADINGVQSHRVIRPGRHKCRQTFAPAGIFPASIGGWRPGWRLLLTLNGGHPVTRGFAPCLANTNRQNLDRCAFRRIVVKAHFSNVDHNAVANRGGQDKLLRHHQRGARFRQEHIDARVGLQHIAQALAVLSGKGLKRLGIVLRNRDGQRAAYQTASFRRQRVAHRQSALAGEKHNKRTKQFHAPHNFPSSVAIIVNEL	MPFAIYVLGLAVFAQGTSEFMLSGLIPDMARDLGVSVPAAGLLTSAFAVGMIIGAPLMAIASMRWPRRRALLTFLITFMLVHVIGALTSSFEVLLVTRIVGALANAGFLAVALGAAMAMVPADMKGRATSVLLGGVTIACVAGVPGGAFLGEIWGWRAAFWAVVVISAPAVVAIMFATPAEPPAESTPNAKRELSSLRSRKLQLMLVLGALINGATFCSFTYMAPTLTDISGFDSRWIPLLLGLFGLGSFIGVSVGGRLADTRPFQLLAVGSAALLTGWIVFALTASHPAVTLVMLFVQGALSFAVGSTLISQVLYAADAAPTLGGSFATAAFNVGAALGPALGGLAIGMGLSYRAPLWTSAALVTLAIVIGAATLSLWRRPASVQETVPA	77.49	gnl|BL_ORD_ID|1599|hsp_num:0	1744			330	471	chloramphenicol
BGC0000446.1|Tilivalline_5 # 3499 # 3813 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.492	BGC0000446.1|Tilivalline_5 	3499	3813	-	Loose	1800	25.409	mexY	29.41	3003033	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTCGCCGCGGGTGAGAAGGCGGTGCAAAATGTGTATGAACATCATCTTCGCCCGACGGAAAAACAGCATCATCCATGGATAGAGCGCATTACCCGTCAACTGCTAGCGGCCTGCAGGGAATGGAATACGCTACTGGAAGATCGTCCGATTGCTACGGACCCCGATCAGGTTGCCGTGACAAGTACGGTTATCTGGACCTTTATTCAGGCCAGGATCCCCGATATTGTTGATGCGCAAGAGTTTCGTCACATTCAGTCGCTTGCCGAATTATTTGAAAATCATGCTGCGTTTAAAAAACATCCCTATCGCTGA	MLAAGEKAVQNVYEHHLRPTEKQHHPWIERITRQLLAACREWNTLLEDRPIATDPDQVAVTSTVIWTFIQARIPDIVDAQEFRHIQSLAELFENHAAFKKHPYR	MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDIGRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFFLVVGRLFRLRKAPRTGNSPQIPTEQA	9.94	gnl|BL_ORD_ID|1640|hsp_num:0	1786			2406	2538	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
BGC0000446.1|Tilivalline_6 # 4283 # 5188 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.542	BGC0000446.1|Tilivalline_6 	4283	5188	+	Loose	550	139.813	NmcR	32.52	3003665	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NmcA beta-lactamase	ATGGCGGATTTTCCCCCGATTGCGAGTTTACGTAGTTTTGAAGCCGTGGCTCGTCTTGGCAGCGTTACGCTGGCGGCGAAAGAACTACACGTTACGCACTCAGCTATCAGTCAGCAGATTAAAGTGCTGGAGGAGAGGGTCGGCTTAAAGCTGTTTATTCGTCACGGTCGCGGCCTGCAGATTAATGAAGAGGGACGACTCTACGCCTTGCAGGTACGCGAGGCCCTTAACCATATCGCTGACGCCACCCGACTGGTGCAGGTAAAGCCCCGCAGACAGGAGCTGACGATAGCGGTGGTACCCTCTTTTGGAGGCCACTGGCTTTTGCCTCGTCTTGAGCGGTTTCGGGCGAAATACCCTCAAATCACGCTGCGAATACAGGCAAACCTGGCGGTCACTCATCTGCAGCAGGAAGGGGCAGATTTGGCCATCCGCATGGGAAAAGGGGACTGGGAAGGCACGGAGAGTCATTATCTTTTCTCCGATGAGCTTATCGTTGTGGCTGCTCCATCTTATAACGGCGGTGAGCTACCCCGTACGCCGTCAGAGATAGCGCAGAGCAAGATTATCTTTTCCATGGAATCGTGGAAAACCTGGTGTATCAAGGCAGGGCTTGAAAGAGAGATTGTGCCCGGCGGGCTATGCATAAACGACTCAAATCTGGTGCTGGAGGCCGTCCGGCTCGGTAAAGGTGTTGCGCTGGAACGCCGATCTTTAGTCCAGGATGCTATTGCCCGGGGAGAGCTGGAACAGCTTACCCCTTTCGCCGCGCCTTATCCGTGGCCTTACTGGCTGGTCTCATCGCAAGTTGCAGAAAAGAAAAACGAAGCTGTGCTTTTTAAGGACTGGCTTAGTGAGGAGGTTGTTGCCTGGCGTCAGCAAACGGCAACGGTAGAAGAGAGATAA	MADFPPIASLRSFEAVARLGSVTLAAKELHVTHSAISQQIKVLEERVGLKLFIRHGRGLQINEEGRLYALQVREALNHIADATRLVQVKPRRQELTIAVVPSFGGHWLLPRLERFRAKYPQITLRIQANLAVTHLQQEGADLAIRMGKGDWEGTESHYLFSDELIVVAAPSYNGGELPRTPSEIAQSKIIFSMESWKTWCIKAGLEREIVPGGLCINDSNLVLEAVRLGKGVALERRSLVQDAIARGELEQLTPFAAPYPWPYWLVSSQVAEKKNEAVLFKDWLSEEVVAWRQQTATVEER	MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQLTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENPWIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPSDLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQKELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS	102.03	gnl|BL_ORD_ID|1905|hsp_num:0	2072			15	861	cefoxitin; cefazolin; ampicillin
BGC0000446.1|Tilivalline_7 # 5613 # 6845 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=TAAAA;rbs_spacer=14bp;gc_cont=0.436	BGC0000446.1|Tilivalline_7 	5613	6845	+	Loose	500	179.874	bcr-1	38.35	3003801	protein homolog model	n/a	n/a	bicyclomycin-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCGACCGAAAGAAGTTCAGGCATCGGCAGTCAGTACGATGTTCAGAGATGAAAGTAGAGGTTTGCTTTCCAGTAAAGTCGTTATTGTTCTCGGTTTACTTAGCGCCGTTGCTGCATTATCCACTGATATGTACTTGCCTTTATTTCCAGCTATCGCCAGCGATCTGCATACGACGCCTGACAAAGTTCAGCTTAGCATCACCGCTTTTATGGTAGGCTTAGGTATTGGGCAGCTGTTTATTGGACCATTATCCGATCATTACGGCAGACGTAAATTATTGCTGGGCGGGATGGCCCTATTAACCATCGCTTCATTAGCTGGCGCTATATCTACGAACATTCAGCTGCTCATTGTTACACGGTTCTTTCAGGGACTGGGAGGAGCGGCTGGTATCGTTCTTTCCCGAGCAATTATTTCTGATCTGTGCCCGGGGACTAAAGCCGCTCGATATTTTAATCTGGTGCTAGCGATACAGGGGATCGCCCCTGTTATTGCACCATTACTTGGAGGAGTGGCTGCATGGTTTATCTGGCCGGTAGTTTTTGTTTTTATGGCTACAATATCATTAGTTTCCACTCTGCTCAGTAGTCATTTTATTAGCGAAACCTTACCCCGTCATCAGCGATTACCTTTCAATCTGAATGAGTTTATCAGTCAGTTTATCGAGTTGCTAAGCAATAAGAAATATATTGGTTATACTCTAATTTTTTCAATCCAGTTTGGGGCGCTATTTGCTTATATATCAGCATCACCATTTATCTATCAATCGACGTTCGATTTATCCTCAGGAAAGTTCGCTGTAATATTCTCTATCAACGCCGGAGCAATGATGTTTGGTAGTATAGTCAGCGCTCGCTATGTTATGAAATTTGGTGAAGATAACCTCATAACCATGGGGGTGATAAGCACGCTGGTGATATCTATATTGCTTTGTATCGTTGACAATATTTCTCATTTCCAGTTTGAGATCGCGGCGGTACTACTGTTAATGATGATGTTTACTATGGCTTTGACATTTGGCAATGCCGCGAGTATGGCCATGGCGGCATCCTCTCACTTAAAGGGAACGGGTTCTGCTATTTTAGGGGCTTTTCAGTTTGGTATCGCTGCGATAACCCCGTCACTGCTTGGATTTGGAGACCCGTTGTCATTACTGCCTATGTCGCTGATTATCGCGGGATGTTGTTTAATTGCCATCATGGCATTGTTATTGACAGGTAAAAAAGGATAG	MRPKEVQASAVSTMFRDESRGLLSSKVVIVLGLLSAVAALSTDMYLPLFPAIASDLHTTPDKVQLSITAFMVGLGIGQLFIGPLSDHYGRRKLLLGGMALLTIASLAGAISTNIQLLIVTRFFQGLGGAAGIVLSRAIISDLCPGTKAARYFNLVLAIQGIAPVIAPLLGGVAAWFIWPVVFVFMATISLVSTLLSSHFISETLPRHQRLPFNLNEFISQFIELLSNKKYIGYTLIFSIQFGALFAYISASPFIYQSTFDLSSGKFAVIFSINAGAMMFGSIVSARYVMKFGEDNLITMGVISTLVISILLCIVDNISHFQFEIAAVLLLMMMFTMALTFGNAASMAMAASSHLKGTGSAILGAFQFGIAAITPSLLGFGDPLSLLPMSLIIAGCCLIAIMALLLTGKKG	MPASASRIQVGSGERRLLLLLSALVAFGPLSIDMYLPSLPAIAADLGASDAQVQRSISGFLVGFCVGMLFYGPLSDRFGRRPVLLAGIALYLFSSLACALADSAGQLVLLRVLQALGGGAASVLARAMVRDLYPLGEAARMLALMHMVTMLAPLAAPLLGGYLMLWAGWRALFVVLALFAGLCLLAVWRVAESHPPERRGGSLAQAFLAYGRLLGDRRALGYVLCMGLAFAGMFAYISAAPFVFIEHFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSLLACVSGLFLLGYAALGERGGLWALVPGLLCFVSVTGLLGANCIASLLALYPGQAGAASAVAVSGQFGLGCLASLAVGWLALPGVLPMALVMAVCGVGSLLALGLALHGGNR	101.99	gnl|BL_ORD_ID|2332|hsp_num:0	2303			69	900	bicyclomycin
BGC0000446.1|Tilivalline_8 # 6850 # 9072 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=13bp;gc_cont=0.457	BGC0000446.1|Tilivalline_8 	6850	9072	+	Loose	950	50.8322	msrE	22.56	3003109	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGAAAACCCATGACGCTATAAAAATCATTGGTGCAAGGCAAAATAATTTGCAAGATATTGATGTAGAGGTCCCTAAAAATAAAATAACAGTTTTTACCGGTGTTTCCGGATCGGGTAAAAGCTCTTTAGTATTCGGAACTATAGCGGCGGAATCTCAGCGACAGTTAAATGACACGTTTCCACCTTTTATTCGCCATCGCTTACCACATTATGGTAATCCTGAAGTCGATGAAATTGAAAACCTGTCGGTGGCCATTATTATTGACCAAAAACGTATTGGTGGCAACGCACGTTCGACGGTGGGCACCGCATCAGATATTTATACCCTACTACGGCTACTCTTTTCTCGTGTCGGCGAACCTTTCGTAGGTTATTCGAATGTTTTTTCATTCAATCATCCTGCGGGGATGTGTGCGACATGCGACGGGTTGGGCATTGCCAGTACTATTGATATCAACCATCTGATTGATTCAAATCTGTCGTTAAATGAAGGAGCTATTCGTTATCCTTCTTTTGCGCCAGGCTCATGGCGCTGGAAACGTTATGTTTATTCAGGACTTTTTGATGCCGATAAAAAAATCGCGGATTATTCAAAAGAGGAGCGAGAATTATTACTTTATGCGGATAATCTCACTCCTGAAGCGCCGTTAGCCGGTTGGCCTAAGAGTGCAAAGTTTGAAGGCGTCATTACGCGCTTTACGCGAAGTTATTTAAAACAAGAAACTAAAGATACTAAAACTGAGGAATTTCAGCGAGTCGTTAGTTTGCAGGTTTGCCCTTCTTGTCAGGGTATGAGGCTTAACGAGGAAATACTTTCCTGCCGGATTAGAGGGAAAAATATTGGCGAATGCGCAACGCTGCCTGTCACAGAGTTAAAGCTGTTTGTAGAAAAGCTCGATTACCCTGAAGTCAGGCCGCTGATCGAAGCATTGCTGGAAAGGTTGGATGCCATGTGTGCAGTAGGCTTGGGATATCTGGATTTGAACCGTACGACCCCTAGCTTATCGGGCGGTGAGTCCCAGCGGTTGAAAATGGTCCGACATCTGGGAAGTAGTCTGACCGGGATCGTTTATATAATTGATGAACCCAGTACCGGCCTGCATCCAGCAGATATAGTGAAATTGAATGTTTTAATTGGAAAACTACGCGACAAAGGCAATACCATTCTGATGGTGGAGCACGACCCGGACATGATAGCGATAGCCGAGCATGTTATTGATTTAGGGCCAGGAGCGGGTAAGCAAGGCGGGAATATTGTCTTTGAGGGCGACCTGTCGGCACTTAAGCAATCCCAAACCTTGACGGGTCGATATTTCTCTTCACGGGCAGAGATAAATAAGAAACCGAGATGTGCCAAGGGTTATATATCGGTAAGAAACGCCACATTGCATAACCTGCATAACTTATCGGTAGACGTGCCTTTAAGCGTTATGGTCGCTGTGACGGGAGTCGCTGGATCGGGCAAAAGTTCATTCGTTATGGGGGCCCTGGCGCCACAATGTCCGGAGGCGATCGTTATCGATCAAAAACCGATACATACCTCAATTCGATCGCATATTGCTTCCTGGTGCGGTGCATTTGATACGATCCGTTCGCTGTTTGCCGAAAAAAACCATGTGTCAGCGTCGTGGTTTAGCGCTAATGCCAAAGGGGCTTGTCCGGAATGTAATGGGCTAGGGGTAATACAAACCGATCTGGCATTTATGGATACGGTTACGTTGCCATGTGAGGCCTGCCAGGGGCAGCGCTATAACCCACAAGCGCTGAAATATCGTTATCAGGGAAAAAGTATTGCTGAGGTATTATCCCTGTCGATTAATGATGCCTGCGAATTTTTCCTTAATGAGCCACAGCTCAGGCCAATTTTTCGTAGCCTGGTCGAAGTCGGGTTGGGATATTTACGCTTGGGTGAATCGTTAAATCATCTTTCAGGCGGTGAATGCCAGCGGCTGAAGTTAGCGTCACAATTAAATCATGATAGTGACATGTATATTTTCGATGAGCCAACCACGGGTCTTCATCCCAGTGATGTAGCCTCGCTGTTGAAACTATTTAACCGACTGGTAGCGCGCGGAAACACCGTCATTATTATTGAACATAATATGGAGTTGATCGCTCAGGCTGACTGGATTATTGATATTGGACCTTATGCCGGGAAAGAAGGGGGGGATTATTGTTTAGCGGTACACCCGAATCGATGCTGGCCTGTCGCCATTCATTAA	MKTHDAIKIIGARQNNLQDIDVEVPKNKITVFTGVSGSGKSSLVFGTIAAESQRQLNDTFPPFIRHRLPHYGNPEVDEIENLSVAIIIDQKRIGGNARSTVGTASDIYTLLRLLFSRVGEPFVGYSNVFSFNHPAGMCATCDGLGIASTIDINHLIDSNLSLNEGAIRYPSFAPGSWRWKRYVYSGLFDADKKIADYSKEERELLLYADNLTPEAPLAGWPKSAKFEGVITRFTRSYLKQETKDTKTEEFQRVVSLQVCPSCQGMRLNEEILSCRIRGKNIGECATLPVTELKLFVEKLDYPEVRPLIEALLERLDAMCAVGLGYLDLNRTTPSLSGGESQRLKMVRHLGSSLTGIVYIIDEPSTGLHPADIVKLNVLIGKLRDKGNTILMVEHDPDMIAIAEHVIDLGPGAGKQGGNIVFEGDLSALKQSQTLTGRYFSSRAEINKKPRCAKGYISVRNATLHNLHNLSVDVPLSVMVAVTGVAGSGKSSFVMGALAPQCPEAIVIDQKPIHTSIRSHIASWCGAFDTIRSLFAEKNHVSASWFSANAKGACPECNGLGVIQTDLAFMDTVTLPCEACQGQRYNPQALKYRYQGKSIAEVLSLSINDACEFFLNEPQLRPIFRSLVEVGLGYLRLGESLNHLSGGECQRLKLASQLNHDSDMYIFDEPTTGLHPSDVASLLKLFNRLVARGNTVIIIEHNMELIAQADWIIDIGPYAGKEGGDYCLAVHPNRCWPVAIH	MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEATLQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHGILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGGYSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAGRLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITADGLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYFTQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLSKMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKDHKIIKTFERDC	150.71	gnl|BL_ORD_ID|27|hsp_num:0	33			279	1443	erythromycin
BGC0000446.1|Tilivalline_9 # 9195 # 10712 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.490	BGC0000446.1|Tilivalline_9 	9195	10712	-	Loose	900	28.8758	otr(B)	40.74	3002892	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAAAATAAATCAGTATCATTACCTACCGGTAATGACTTTTTAGCGGGTCTAAATGATGGGCGAGAAATATGGGCTTATGGTGAAAAGGTGGACAATGTTATTACACATCCAGCGTTTCGCAATTCAGCACTGTCCATAGCTAAATTATACGACGCGCTCCATGACGAAAAGTATCAGGCTATATTAACCACGCCTTGTGATACCGGCAGCGGTGGTGTCACTCATCCGTTCTTCCGCGTTCCTCATTCTGTTGAGGATCTGATACGCGATCGCGACGCAATCGCGCAGTGGGCACGGCTTAGCTATGGCTGGTTGGGAAGAAGCCCTGATTTCAAAGCGTCGTTTCTTACGACTCTGGGCGCCAATCCCGAGGCCTACGGCGAATATACGGATAACGCCAGGCACTGGTACAAACGTTCGCAAGAGGAGCTACTTTACTGGAATCATGCCATCATTAACCCCCCTATCGACCGCAATCTCCCGCCCGACCAGATTGAAGATATCTGCATTCACGTCGAAAAAGAGTGTGATGATGGCGTAATTGTTAGCGGTGCCAAGGTGGTTGCTACCGGCTCAGCTTTGACGCATTACAATTTCATCGCGCATTACGGTTTACCTGTCAAAAAAAGAGAATTTGCCCTGGTATGCACATTACCCATGAATGCCCCAGGACTGAAGCTGGTTTGCCGCCCCTCTTACTCCTTAGCCGCCGAAAAGGTCGGCAGTCCTTTTGACTATCCACTATCCTCACGCTATGACGAGAATGACATGATCTTCATTCTGGATAAGGTGAAGATTCCCTGGGAAAACATTTTTATTTACGGCGATACCGCTAAAGCGGCCACGTTTTTACCCAGTTCTGGCTTCCTGCACCGCTCAACCTTCCACGGAGTGACGCGTCTGGCGGTAAAAATTGATTTTATTTGTGGTTTATTCATTAAAGGCGTGGAAGCCACCGGCGTAGCCGATTTCCGCGGCATACAGACGCGCGTCGGGGAAATGCTGGCCTGGCGCAACCTCTTCTGGGCCATAAGTGATGCTATGGCTAAATCGCCGAACCCCTGGCACAACGGCGCCCTCCTGCCTAACCTGGATTATGGTTTAGCCTACCGTTGGTTTATGAGTCTCGGCTATCCACGGATCAAAGAAATTATTGAACAAGATCTTGGCAGCGCGCTTATTTATATCAATTCGCATGCCAAAGATTTCGCTGCGCCGGAACTGGAACCTTATCTGAAAAAATATATGCGGGGCTCCAACGGTATGGATGCCGTTGAACGCGTCAAGCTCATGAAGCTAATCTGGGACTCCGTAGGAACAGAATTCGCCAGCAGACACGAACTCTATGAACGAAATTATACCGGTAGTCATGAAAATGTTCGTATCGAGCTGTTGCTCGCCGCACAGATGTCGGGGCAGGTACAAGAATATAAAGGTTTCGCCGAACAATGTATGATGGATTATGACCTGGATGGCTGGCTGGATCGCGATTACCACTGGCCTTTAGACGAATAA	MENKSVSLPTGNDFLAGLNDGREIWAYGEKVDNVITHPAFRNSALSIAKLYDALHDEKYQAILTTPCDTGSGGVTHPFFRVPHSVEDLIRDRDAIAQWARLSYGWLGRSPDFKASFLTTLGANPEAYGEYTDNARHWYKRSQEELLYWNHAIINPPIDRNLPPDQIEDICIHVEKECDDGVIVSGAKVVATGSALTHYNFIAHYGLPVKKREFALVCTLPMNAPGLKLVCRPSYSLAAEKVGSPFDYPLSSRYDENDMIFILDKVKIPWENIFIYGDTAKAATFLPSSGFLHRSTFHGVTRLAVKIDFICGLFIKGVEATGVADFRGIQTRVGEMLAWRNLFWAISDAMAKSPNPWHNGALLPNLDYGLAYRWFMSLGYPRIKEIIEQDLGSALIYINSHAKDFAAPELEPYLKKYMRGSNGMDAVERVKLMKLIWDSVGTEFASRHELYERNYTGSHENVRIELLLAAQMSGQVQEYKGFAEQCMMDYDLDGWLDRDYHWPLDE	MSSANPGPAGTADQAGGAFTHRQILTAMSGLLLAVFLAALDQTVIATAMRTIADDLHGQTEQAWATTGYLIASVLAMPFYGKLSDIYGRKPMYLISIVVFIGGSVLCGTAGSMWELALFRAVQGLGGGGLMSLPTAVVADLAPVRERGRYFAFLQMAWVVASVAGPLAGGFFAEAGQVFGIDGWRWVFLLNVPLGLLALVTVRKALNLPHERREHRMDVLGAAALALFLVPLLIVAEQGRTWGWGSPAALALFALGAAGLAVFIPVELRRGDEAILPLGLFRRGSIALCSAVNFTIGVGIFGTVTTLPLFLQMVQGRTPTQAGLVVIPFMLGTIASQMVSGKLIASSGRFKKLAIVGLGSMAGALLAMATTGATTPMWGIVLIVLWLGVGIGLSQTVITSPMQNSAPKSQLGVANGASGLCRQIGGSTGIAVLFSVMFAVALGRLADLLHTPRYERLLTDPAITGDPANHRFLDMAESGQGAGINLDDTSLLNGIDARLMQPVTDSFAHGFHIMFLAGGVVLLAGFVMTWFLRELQEETAPEEERPAESGAGAKNGPLPASDA	89.70	gnl|BL_ORD_ID|889|hsp_num:0	870			1314	1395	tetracycline
BGC0000446.1|Tilivalline_10 # 10751 # 12703 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=ACG;rbs_spacer=15bp;gc_cont=0.494	BGC0000446.1|Tilivalline_10 	10751	12703	-	Loose	450	26.5646	tet(45)	34.07	3003196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGATGTTATCTAAAGATTCAGCAAATCCCGACGAGCTTTCGGCTCATCTGGCCAATCTTGATAGACCCTTTGCCTGTATTTATCGCCCCCAATGCGAACCTATCAACGCAGTATTGTTTCTTGAAGGGGATATTGAGCTAAGCCAGTCCCTTTCAGAATTAGCGCTGGATCCTCCCCTGGACGCGACGGGCAAATGCTCATTTAACAAATTGATATTATTGCCATTTAATCAGCTGAAAGAAAAAGGATATGCCTGCATTGACGATGGTGAACAGACGATCGTAATGCACATTGAGCGGCAAGACTATTATCCTATAGATTCATTTATCGCAGCCATTAATGACCATGATATCAAGCCACGAAACCTGCACTTCGATCTTGATGACCAAACGTATGGCGACATTGTTGATACCGTGATTGATCAGGAAATCAGCTCCGGGGAAGGCAGCAACTTTGTGATTTCACGCAGCCTGGAGGGCGATATAATCGACTTTAGTATCCGCCACGCGCTGACGCTGTACAAACGGCTGCTGCAATCTGAATGCGGATCATACTGGACATGGATGATCTTTACCGGCAGCCGCTATTTCATGGGTAGTACGCCTGAACAGCATATCCAGGTTGATGAGCAGAACGTGGCGATGAATCCTATCAGCGGCACATTAAAATACCCCGATACCGGGAATATGGCGCACGTGCTGGATGATTTTCTGCAGGATAAAAAAGAGCGCGACGAACTATTTATGGTGGTAGATGAAGAACTCAAAATGATGAGTAGCATCTGTCAACGTGATATTCAGGTATCCGGGCCGAAGCTCAAGGCTATGTCGCACATCGCGCATACCGAATATTTTATCCATGGAAAATCAGATCGCAGTCTGAAAGAAATCATCAGGCAATCGCTATTTGCGCCAACAGTGACCGGCAGCCCAATAGAAAGCGCCTGTAAAGTTATCGCCCGGCGAGAACGCCGCGGACGCGGTTATTACAGCGGCATCGTTGCTATAACGGGTGCGCAAGAAGGTAAACGCTATCTGGACTCGGCCATCATGATCCGCACGGCCGATATTTCCGCTCAGGGACATTTTCGGCTTACGGCGGGTTCAACCATCGTCAGAAGTTCCATCGCGCAAAGTGAAGCCGGTGAAACACGCGCCAAATTACAAGGGCTAATGCATTCGTTCTTCTCTGAACCAAGCGCCGGGACGCCAAACCGGACAGGATTGTCTGCAGAACTTTGCCATCGGGCTGACCAGATACTGGCACAACGGAATGCACGCACCTCCGCCTTTTGGCTGGATAACTCGCAATTGGGCCCGCGCACTCTACTCTCTCATCATGCCATCACACTGATCGACATGGAGGACAACTTCACCGCCATGATTGCCTATCAGTTACGCAGCGCGGGTTGCGCCGTCACCCTCATTCCCTGGTATGACTGTCCGAGCAAGCTAACGCAACTCACCGATCGCGACATCCTATTCATTGGTCCCGGGCCTGGCGATCCAACCAATATACAACTCGAAAAAATACGCGTGGGCCGAAAAATTATTGCGCAACGGCTCCGGGAGCAGCGTCCGCTAATCGGAACTTGTCTGGGACATCAGTTAATTTGCGCCGAATTAGGCATTCCGATCGAGCGGCTGGTCAATAACCGTCAGGGTAGCCAACATCAGATATCCATTCAGGGGAAACCTCATACCGTTGGTTTCTATAACAGTTTCTCCGCACTACATCAGCGGCCATGCTGGTACAGCCCGGAGCATGACAAAACAGTCCAGCTGGAGCGACTTCCTTCCGGTGAAATTGTCGCATTATCGTCAGGCAACGTTGCCTCCATACAATTTCATAACGAATCATTCCTGACGCAAGACGCATTTTCTATTTATCAATGGCTGATACAGAACGCCTTAACAACAACGGCAACTCTTAGCCAACAAGATGCCGTTTAA	MMLSKDSANPDELSAHLANLDRPFACIYRPQCEPINAVLFLEGDIELSQSLSELALDPPLDATGKCSFNKLILLPFNQLKEKGYACIDDGEQTIVMHIERQDYYPIDSFIAAINDHDIKPRNLHFDLDDQTYGDIVDTVIDQEISSGEGSNFVISRSLEGDIIDFSIRHALTLYKRLLQSECGSYWTWMIFTGSRYFMGSTPEQHIQVDEQNVAMNPISGTLKYPDTGNMAHVLDDFLQDKKERDELFMVVDEELKMMSSICQRDIQVSGPKLKAMSHIAHTEYFIHGKSDRSLKEIIRQSLFAPTVTGSPIESACKVIARRERRGRGYYSGIVAITGAQEGKRYLDSAIMIRTADISAQGHFRLTAGSTIVRSSIAQSEAGETRAKLQGLMHSFFSEPSAGTPNRTGLSAELCHRADQILAQRNARTSAFWLDNSQLGPRTLLSHHAITLIDMEDNFTAMIAYQLRSAGCAVTLIPWYDCPSKLTQLTDRDILFIGPGPGDPTNIQLEKIRVGRKIIAQRLREQRPLIGTCLGHQLICAELGIPIERLVNNRQGSQHQISIQGKPHTVGFYNSFSALHQRPCWYSPEHDKTVQLERLPSGEIVALSSGNVASIQFHNESFLTQDAFSIYQWLIQNALTTTATLSQQDAV	MNTPHSHSNLRHNQILLWLCVLSFFSVLNEMVLNVSLPDIASDFNKEPASINWVNSSFILTFSIGTAVYGKLSDQLGIKKLLLFGIIVNCFGSVIGFVGHFFFPVLILARFIQGVGAAAFPALVMVVIARYIPKENRGKAFGIIGSIVTMGEGVGPSVGGVIAEYAHWSYILLLPVVTIITVPFLAKLLKQEEVIKGSFDTKGIIFMSVGIVFFIMFTTCYRVSFLVVSIICFLIFVKNIRKVSNPFINPSLGKNVSFMIGIICGGLIFGTVAGFISMVPYMMKDVYQLSTAAIGSGIIFPGAMSVIVFGYIGGLLVDKKGSLFVLTTGVAFLSISFLVAALFIETTPWLITIILIFVFGGLSFTKTVISTIVSSSLEQKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIHLLNRKLLPINAEPSTHLYSNLLLLFAGITIISWLVTIKMHKRSRGNI	141.92	gnl|BL_ORD_ID|146|hsp_num:0	17			1089	1329	tetracycline
BGC0000446.1|Tilivalline_11 # 12730 # 13362 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.504	BGC0000446.1|Tilivalline_11 	12730	13362	-	Loose	300	30.4166	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide	25.71	3003394	protein variant model	W68L, D136H, C72W	n/a	pyrazine antibiotic	antibiotic target alteration	Pyrazinamide resistant pncA	ATGGAAAAGATACGGCCCTATCCATTGCCGACAGAACGTCAATTACCCAAATCAATTGCAGACTGGCGACCCAACAGTTCAAGAGCGGCGCTACTCATACATGATATGCAGCGTTATTTTCTCGATTTTTACACTGCTGACGCCTCGCCGATAGCGCAGGTCATCGACAACATCTACCGCTTGCTTAGCGTCGCCCGACGTCTGCATATTCCAGTATTTTATACTGCCCAACCCGGCGACATGACGCCACAACAGCGCGGCTTGCTGCACAGTCTATGGGGTTCAGGCATGAACGGCAGCCAGGAACATAAACAGATTGTTCCTCCGTTGACGCCTCTGGAAAATGAGTGGGTATTAACGAAGTGGCGTTACAGCGCCTTCTTTAACTCTCCTCTTCTGAGTACTTTGCACGAACTCAAATGCGATCAGCTGATCGTCTGCGGCGTTTACGCCCATATCGGTTGTTTGTGCACAGCGCAAGAGGCCTATTCCAATGATATCGAGACATTTTTTATTGCCGATGCGCTCGCCGATTTCTCCGAAGAAAAGCATCGTCTAGCGCTTGAGCTAGCTGCGGAAACCAGCTCAGTCGTGCTGTCAACCCGACAAGCTATCGACGCATTGGAACATTAA	MEKIRPYPLPTERQLPKSIADWRPNSSRAALLIHDMQRYFLDFYTADASPIAQVIDNIYRLLSVARRLHIPVFYTAQPGDMTPQQRGLLHSLWGSGMNGSQEHKQIVPPLTPLENEWVLTKWRYSAFFNSPLLSTLHELKCDQLIVCGVYAHIGCLCTAQEAYSNDIETFFIADALADFSEEKHRLALELAAETSSVVLSTRQAIDALEH	MRALIIVDVQNDFCEGGSLAVTGGAALARAISDYLAEAADYHHVVATKDFHIDPGDHFSGTPDYSSSWPPHCVSGTPGADFHPSLDTSAIEAVFYKGAYTGAYSGFEGVDENGTPLLNWLRQRGVDEVDVVGIATDHCVRQTAEDAVRNGLATRVLVDLTAGVSADTTVAALEEMRTASVELVCSS	112.90	gnl|BL_ORD_ID|1945|hsp_num:0	851			6	519	pyrazinamide
BGC0000446.1|Tilivalline_12 # 13381 # 14166 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.559	BGC0000446.1|Tilivalline_12 	13381	14166	-	Loose	500	32.7278	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	29.23	3003393	protein variant model	I194T	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	ATGACTTTTGATAAAGATTATATTGCCGTTATTACCGGCGCATGCGGTGGCATTGGCGAATCCGTTGCCCACGCGCTGGCGAAAGAAGGGCTGTCACTAGCGCTTCTTGATAATAACGCCACTCAGCTGGCAACCCTTGTAGCCACACTACAAGATAACCATCCGCAGCCCATTGCAGGCTTTACTGTAGACGTTGCCGACGACCGCTGCGTAGCAGAGGCCTTTACCGCAGTCGGTCATCAACTGGGCCCGGTAGGGTATCTGGTCAACGGCGCCGGCGTACTGTGCCACGCCAGCGTGGCCGAAACACAACCTCAGGATTGGGCGAAAACATTTGCCGTCAACGCGACTGGCGTATTTAACACCAGCCGCCATGCGGCCAATCTGATGATGGCTCAGCGTAAAGGCAGCATCGTAACTATCGCCTCAAATGCAGCGCGCGTGCCGCGGGCGACGATGGCCGCCTACTGCGCTTCAAAAGCCGCTGCCCAGGCATTTACCTATGCTCTGGGGCTGGAGGTCGCTCCGTATGGGATCCGTTGTAATGTTGTCGCTCCCGGCTCAACCGATACGCCGATGCTGCGCGGCATGTGGCATAGCGAAAGTGACAAGCAAAACACGCTCAACGGTAACCCACAACAATTTCGCATTGGTATTCCACTCAACAAAGTCGCTACGGCGGAAGAAATTGCTGCCGCGGTCTGCTTTTACCTGTGCGAAGAATCAGGGCAAACCACGCTATCAACGTTATTGGTCGACGGTGGTGCCGCACTCGGCAGCTGCTAA	MTFDKDYIAVITGACGGIGESVAHALAKEGLSLALLDNNATQLATLVATLQDNHPQPIAGFTVDVADDRCVAEAFTAVGHQLGPVGYLVNGAGVLCHASVAETQPQDWAKTFAVNATGVFNTSRHAANLMMAQRKGSIVTIASNAARVPRATMAAYCASKAAAQAFTYALGLEVAPYGIRCNVVAPGSTDTPMLRGMWHSESDKQNTLNGNPQQFRIGIPLNKVATAEEIAAAVCFYLCEESGQTTLSTLLVDGGAALGSC	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	97.03	gnl|BL_ORD_ID|1964|hsp_num:0	1574			423	792	isoniazid
BGC0000446.1|Tilivalline_13 # 14156 # 15325 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.508	BGC0000446.1|Tilivalline_13 	14156	15325	-	Loose	670	28.4906	Escherichia coli acrA	31.15	3004043	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACATCATTTCCTGGCAATAAGTCCAACTGGCAACAGCCGTTCTGGAGCGATAAGGACATGCTTGCCCTGGTCAAAAGTGAATTAGACAATCTTCCAGAATTATTAAGTTTTGCAGAAATAAGTGAACTCAAGAAAGCATTAGCCGCCGTTTATGCAGGAAAAACAATGATATTTCAGGCCGGCGACTGCGCTGAAAGAATTTGCGAATCTGGCGCGTTACATGTACGGAAAAAATTGATCTTCCTTGAGCAAATGTCCCGCGAATTCTCAACACTGACGGGGCTGCCGATATTGACGGTAGGTAGAATTGCCGGTCAATATGCTAAACCCCGCTCGCAACAAAACGAAGTCGATGGCGACAGGGTACTTCCCGTGTGGCGCGGTGATTCAGTCAACCGGCCCGAAGCGACACCAGAAGCCAGGCGTAACGATCCGCAACGGATGCTGCTGAGCTATCGTGCTGCTGCGGAAACGCTGGCCGAAATTAAACGTTACGAACGGGAATATCCCCGCGATATTCATCACATTTGGACCAGCCATGAAGCGCTGTTGCTGGACTATGAAACCACTCAAATCCGCACTAATCCCTACGGAGAATCATACTTAGCCAGCACCCATTGGCCCTGGATAGGCATTCGTACTCTTGCGCCTGACAGCCCACATATCGCCATGCTGGCGAATATCGCCAACCCTGTTGCCTGCAAGATTGACGCCAGCGTAACGCCATCGTTCATCGCGTCACTTTGCCGACAGCTCAATCCTCAGCGTATTCCTGGGCGTCTGACTTTTATTTCGCGTTTTGGCCGTTCACACATTCATCGGTTGGGCGCGTTGATTCAGGCCGCGCAAGCAACCGAAACGCCGGTGTTATGGATGTGCGATCCAATGCATGGGAATACCGGGAAAACACGGGCGGGCAATAAACGCCGCGAGCTTAGCGACATGATGGCTGAAATCTCCGGTTTCCTGAGGCAGGTGAAATCACATAACGCCTGCGCCGCAGGACTCCATCTGGAAGCAACGCCGAACCCGGTCATCGAATGCTTCAGTGAAAATAATCACCCTGAAGAACATGAACTTAAGCAAATTCTCTGCGACCCACGCCTGAACGTAGCGCAAACGCAGATGTTATTAACTCACTGGAAAGAGGGACAACATGACTTTTGA	MTSFPGNKSNWQQPFWSDKDMLALVKSELDNLPELLSFAEISELKKALAAVYAGKTMIFQAGDCAERICESGALHVRKKLIFLEQMSREFSTLTGLPILTVGRIAGQYAKPRSQQNEVDGDRVLPVWRGDSVNRPEATPEARRNDPQRMLLSYRAAAETLAEIKRYEREYPRDIHHIWTSHEALLLDYETTQIRTNPYGESYLASTHWPWIGIRTLAPDSPHIAMLANIANPVACKIDASVTPSFIASLCRQLNPQRIPGRLTFISRFGRSHIHRLGALIQAAQATETPVLWMCDPMHGNTGKTRAGNKRRELSDMMAEISGFLRQVKSHNACAAGLHLEATPNPVIECFSENNHPEEHELKQILCDPRLNVAQTQMLLTHWKEGQHDF	MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS	97.98	gnl|BL_ORD_ID|2321|hsp_num:0	2661			543	711	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000446.1|Tilivalline_15 # 16014 # 17303 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.502	BGC0000446.1|Tilivalline_15 	16014	17303	+	Loose	1000	83.9593	almE	24.87	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCTGGCGCTCATGAAAATAGGCGCTGTTATGGTTCCCGTGAACTCGAATAGTCCCGAACGCTATATTGGTGAGGTTTTAAGTGCGGCGGGAGCCAGATACCTGATTAGCGATGATGTAACAAGCGTGCCCGGCGGAGCATGGCACGTCTTGTCGAGCAGGACGCTGATACAAAACTGCACGCAACAAAGAAGCGGGAATTACCCGGTATTAAGTGCTGATGATCCGGCGCTCATATTGATGACCTCTGGTTCAACAGGAAAACCGAAAAGCGTACTGATTGCTCATCGCGGGATTGCCAGACTGGGTCTGCCGGTACCGGCGTTGGGGAATAGCGAGCGGGACTGCTATTTGCAAATTGCAGATATTTCTTTCGCTGCCTCAGCTAATGAAATCTGGATGGCTTTATTGACCGGAGCATGTCTCGCGATTGCGCCGCCTGGCTTGCCGGATTTAATGGCCCTGGCACGGCAGATCGAATCGGATAACGTGACGATGCTATTCCTCTCTGGCGGGCTGTTCCGGCTATTTGTCGAGGTTTCGGTCGAAACACTGCATATACCTGATTGTGTGGTGGTGTCGGGAGACTTTGTCAATCCTCGCTTATTTAGCGTGGCGGTGCAGGCCGGTAAAGCCAAAATATTTAATGGATTAGGATGCACGGAAAATTCAGCGATCTCGTCTCTCTATCATATTCAGTCGGAGGAGCAATTATCCAGTGAATCTCCTGTGCCGGTTGGTACTCCACTCCCTCTGGTTGAGATGGTGGTATTCAATGAACGGTTGCAACCCTGTACCTGCGGTGAATATGGGGAATTATTTATCGCAGGGGCTGGAGTGGCTCTGGGGTATTCCGATCCGCAACTGACGGCGGAAAGGTTTATCACCATACCGTATCAAGGCACTGACGTGCTTTTCTATCGTACCGATGATCGGGCAACTTACGACCAGGATTGCAATATCGTCCTGGTCGGACGAGGCAACCATATTTGTAAAATACGTGGCTTCCGCATCAATATCGCCGGTATTGAGCACCTGTTGCGCTTACATCACGCTGTAGAAGATGTGCTGATTGTGGTAGAGGAGACGCCGGATGAACCGCGATTACATGCTTGTTATGTCACGCAGGATGACGGGCTATCCGTAGCGGATTTAAAGAATCACCTCGCAATGCATGCTCCTGCCTGGATGATACCTGAAAAATTTAGCCGTCTGGCGGTACTGCCAATGACCGCTAACGGTAAAAAAGATCGTTTACGGTTAAAAAATTCTTTACTGGAGCAGGTGTAA	MLALMKIGAVMVPVNSNSPERYIGEVLSAAGARYLISDDVTSVPGGAWHVLSSRTLIQNCTQQRSGNYPVLSADDPALILMTSGSTGKPKSVLIAHRGIARLGLPVPALGNSERDCYLQIADISFAASANEIWMALLTGACLAIAPPGLPDLMALARQIESDNVTMLFLSGGLFRLFVEVSVETLHIPDCVVVSGDFVNPRLFSVAVQAGKAKIFNGLGCTENSAISSLYHIQSEEQLSSESPVPVGTPLPLVEMVVFNERLQPCTCGEYGELFIAGAGVALGYSDPQLTAERFITIPYQGTDVLFYRTDDRATYDQDCNIVLVGRGNHICKIRGFRINIAGIEHLLRLHHAVEDVLIVVEETPDEPRLHACYVTQDDGLSVADLKNHLAMHAPAWMIPEKFSRLAVLPMTANGKKDRLRLKNSLLEQV	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	77.16	gnl|BL_ORD_ID|4935|hsp_num:0	5928			555	1653	colistin A; colistin B
BGC0000446.1|Tilivalline_17 # 17704 # 21972 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=ACG;rbs_spacer=15bp;gc_cont=0.502	BGC0000446.1|Tilivalline_17 	17704	21972	+	Loose	1000	114.775	almE	25.64	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGTGGTGGCTGGATAATACGCTGGAGCAGCCCCAATGCTATAACGTGCCGGTGCTGCTGACCGTTAATGCGACACTGGACGCTGATATTATGCAGCGCGCTGTGGCTGAGCTGACCTTGCGCCATGAAATATTCAGAACGCGTTTTGTTTATCTTGACGGTAAATTACAACAGCGTATCGGCGCTGATGGCTATCTCTCTTTTTCCCATCGACAACCAGAGCAGACGGAAACCCCTGAATCCGTCACGGCACAACTGGCGGCTAGCCGTTTATCATTAGCTGAGGGGCCGCTGAGTATCATTAATATGCTCAGTTCAGACTCAGGTACAACCTGGTTAGCATGCTGCTTCCACCACATCATTATTGATGCCCCCTCAGTACGTATTGTCTTGCATGATTTGCTGCGAATCTATTGTGCGCTTGACGAGAAGCGCGTTCTGCCAGCGTTTAACGGCACGGGAAGCTATCAGGAATTTACTCGTTGGCAGGCCGCGTCCCTTGCGGCGGCTGAGTGCGAAGATATGCGGGTTTATTGGCGACAGGCACTGCATCCAGCTCCACCCTTGTCGGACCTCCCGGTCGATTTTCCCCGTCGTCTTCGGGAAGATACCAAAGCCGCCTATACCATGCTGGCGCTGAACGAACAGGAAGCGGACTCACTGCAGCGGCACGCGAGATCGTTGTCAATGACTCCATTTATGTATATGTCCATGTGCTGGCAATTTTTCCTCAGCCGTATGAGCGGGCAGAACGATATTACCGTTGGCGTGCCTTTTACTCTGCGGGATCGCAGCGAGTTTGCCGAAACGCCGGGATATATGATCAATACTCTGCCGGTTCGCGTGCAGGTCAATGAAGATGACACGGTCAGCACGCTGGCTGCAAAGGTACGTCAATCTTTTATTGGCGCACATTTCAATAAGCTGCTCCCTTTCAATGAAATTGTCGCACTGTCGCGTGAAAACGCGGGGCAGGACAGTCCTCTATTCAGAACACTGTTGGTTATGCCCGATACCCGGGGCGATATTTTCAACGACTTGCCTTTTAAAGTCATGCTGGATGACTATTTTAGCCAGATGGCAAAATACGATCTGACGCTGTTCTTTGAAGCGCAACCGCAGTGGAAGCTGACGCTGGAGTATAAGACGGCGTTGTATCACCCGCAGACCATTGACTACTGGTTGAAAATCTTTCGCCATTTATTAAGCGCGATGGGTGAGGACGGCGAGGTATTACTGTCATCCCTGAGGCTGTTGGATGCACCGTTAAGTCGTGAACTGGTTGTTCGATCTAGTCTTAAATCGTGCACGGAGGCCTGGCGATTTGACGCCCTGGCGGCTTTCAATCAGCATGCTATAAGCCACTCTGCGGATACTGCGTTAATTACCGCTAATGGCACACGATCGTATGGTTGGTTAGCGGAACGTTCAGGGCAGATTGCCGCTTACCTACAGCAGCAGTTAAATATCGCACCTGGCAAACGTGTTGCATTATTACTGGAAAGGAATGCCGAGGCGATTGCCACTCTGTTTGGCGTGTTAAAAACCGGCGCGGCCTACATTCCGATCGATCCGCAATACCCGCAAGAGCGAATTGGTTACATGTTGCAGGACGCCAGTGTGGATTGCATCGCTACGACGCGATCGCTGGTAGCAAAATTCCCAGTGTCTGGCTCCGTACCTCTGTTGTTAATCGATGATATTCCCCCGGAGTACCCTGGGGAATACTCTTATATCAAAAGAATGCCCGACGATGAGCTGTATATCATTTATACATCAGGTTCAACCGGGCAGCCCAAGGGAGTACGGTTATTAAATAAAACGCTCAATAACCTGATTAAGTGGCAACGAGATGTTTCTGAGTGCGATCAAGGAGATTGTACTCTGCATTTTATGTCACTTTCTTTTGATGTCTCGGTTCAGGAGATCTTCGGCACGTTAGCTGGCGGTGGGTGCTTATATATTGCCAGTGAAGAAGAACGGAGAGATCTGGATCTTCTGCAAGAGGTTATCCAGGAGCAGGGGATTAATCGTCTCTATTTTCCCTATGTTGCTTTGCAACAGTTCGCGCATTTGAGCGTATTGGCCAACAGGCAATTCCCGAGTTTAAAAGAGGTCTACTCCACCGGGGAACAGCTCGTACTCACCGCGGATATTAAACATTTTTTCAGGCAACCCGTTCGCCTGATTAATCTCTATGGTCCCTCAGAAAGTCACGTCTGTTCCGCGTATGTGCTGCCACCGGAAAGCGATAAATGGGGAGATGCAGCGTCCATTGGTTACCCTCTACCCGGATTTACGTTGTTGGTGGTGGATGAGCATTTGCAGCTGGTTCCCGCCGGTGTCGCCGGTGAACTGCTCATCGTTAGCGATTTTCTCTCTCCCGGCTATCACAATAAAAGTGAAGAAAGCGCTCGACGTTTTATCTCTGCTGAGGGCTTTGCCACACAAAGTTGCCACGCATATCGTACCGGTGATCTGGTGAGGCTGGAGCATGACGATCGGTTCAGCTATCTTGGCAGGATAGACAATCAGTTAAAAATTCGCGGTTTTAGGATCGAACCGTCTGAAGTAGAAGCGGCCATCAATGCCCTGGAAGGCGTGCAGGTTTCAGCGGTAGTTGGCAGGGCAGATACTTCAGGAAGCAAGCAGCTCGTCGCTTTTATTGCTGGCTTAATGGATGATAAAAGCAATCAAAAGGATAAGATCAAACGCGGCCTTCGCCTGGTTCTGCCGGAGTATATGGTTCCCACAGAGTTGGTCTTTCTGGATAAGCTGCCTACTACCCCTAGTGGGAAAATCGATCGTAAGGCGTTGCTTAAGGTGGATATTATCGTTGAATCATCCGCGCAGATGCCAGAACGGTCTCTGACGAAAACGCAGGAGCAGGTCAGGGCGCTATGGGAAACGCTATTTCCGGGTCGTCACATCGCACTGCACGATGATTTTTTCGCCATTGGCGGACATTCCTTGTTGGCTACGCAGCTGGTTTTTCTGCTCCGTAAGGCATTCAATTGCGATATTCCTCTACGTTTGTTATTTAATCATCCGACGTTGTTGGCTATGGCAGAGTGCATCGACGGCTATGTTGTCAGTGAAAAGGGGCCCGTCGATACCGTTGATCGTTCCTTTGTTCAGGATGGATACGAACGCATACATTGGCTGGGGGGAGAGTGTTCAACCCCTGGGCTGACGTTGCTCACCGGGGCGACAGGATTTTTAGGCATCTACCTGCTGCGTTCACTGCTATTGGCCGGGACCCAATCCGTGATTTGCCTGGTAAGAGCCAGGACAGATAAGCACGCATTGGCTCGTTTACGTGAAAATGCGATGCGCTACGGAATCGCCGATGAGATTGATTTTTCCCGGGTTGAAGTTTGTCTCGGTGATATTGGTCAGCGCGATTTAGGATTAAGCCCTGACGCGTATAGTCGGTTGGCAGAGCGAGTGGACACGGTATTCCATGCAGCCGCACAGATTAATTTTTTGCTCTCTTATTCTTCTGTTAAACAGTCAAATGTGCAGGGTACGCTAAATATTTTAGCTTTCTGCGGTTGTGGCGGACGAAAAACGCTCCACTATTTATCCACTATCGCCGTATTTTCTCCACGCTATCCTGAATCGCCTATCGTGGAACATTGTGTGCCGGGGCATCCGGAAGCACTGTCGATTGGTTATACGCAAAGTAAGTGGGTGGCTGAACGCTATGTTATACAGGCCAGAGAACAAGGACTTGATGCTAACGTATTTCGCATCGGACGTATTGGCGGAGACAGCCGAACTGGGGCCTGCCAGAGCGATGATTTTTTGTGGCGACAGATAAAAAGCTTTATCCAGATGGGATTGGCGCCCGATCCGTCTTCCCTGTCAACGGACCTGCTGCCTGTCGACTTTGTCGCTGAAGCGATAGTTGCTTTAGCGCGTTCAGAGGCTACTCGACAGGAGAACTTCCATATTTTCCATCCTCAGAGCATCCGGTTTGACCCGGTGTATCGGGCGATTCGTTCTCTGGGCTATCCGTTAGAAACGACTTCTGACGGCGAGTGGTTGCAACAACTTGAGCTGTGTGTCACCCAAGGGCGCGAGGTTGCGCTGGGGCCGGTCATTCATCTCTTTAAAGAGAATTTGTTGGATACTGGCGATAACGCCTATGGTAATCCAGAGACGACTAAGCGTATTACACAACTGGGCTTGCGCTTTCCTGAACTGTCGGAGGAGACTTTCAAACGTATGATTGTTTATTTCCAGCGGCAGAAAGAAATTGTCTAG	MWWLDNTLEQPQCYNVPVLLTVNATLDADIMQRAVAELTLRHEIFRTRFVYLDGKLQQRIGADGYLSFSHRQPEQTETPESVTAQLAASRLSLAEGPLSIINMLSSDSGTTWLACCFHHIIIDAPSVRIVLHDLLRIYCALDEKRVLPAFNGTGSYQEFTRWQAASLAAAECEDMRVYWRQALHPAPPLSDLPVDFPRRLREDTKAAYTMLALNEQEADSLQRHARSLSMTPFMYMSMCWQFFLSRMSGQNDITVGVPFTLRDRSEFAETPGYMINTLPVRVQVNEDDTVSTLAAKVRQSFIGAHFNKLLPFNEIVALSRENAGQDSPLFRTLLVMPDTRGDIFNDLPFKVMLDDYFSQMAKYDLTLFFEAQPQWKLTLEYKTALYHPQTIDYWLKIFRHLLSAMGEDGEVLLSSLRLLDAPLSRELVVRSSLKSCTEAWRFDALAAFNQHAISHSADTALITANGTRSYGWLAERSGQIAAYLQQQLNIAPGKRVALLLERNAEAIATLFGVLKTGAAYIPIDPQYPQERIGYMLQDASVDCIATTRSLVAKFPVSGSVPLLLIDDIPPEYPGEYSYIKRMPDDELYIIYTSGSTGQPKGVRLLNKTLNNLIKWQRDVSECDQGDCTLHFMSLSFDVSVQEIFGTLAGGGCLYIASEEERRDLDLLQEVIQEQGINRLYFPYVALQQFAHLSVLANRQFPSLKEVYSTGEQLVLTADIKHFFRQPVRLINLYGPSESHVCSAYVLPPESDKWGDAASIGYPLPGFTLLVVDEHLQLVPAGVAGELLIVSDFLSPGYHNKSEESARRFISAEGFATQSCHAYRTGDLVRLEHDDRFSYLGRIDNQLKIRGFRIEPSEVEAAINALEGVQVSAVVGRADTSGSKQLVAFIAGLMDDKSNQKDKIKRGLRLVLPEYMVPTELVFLDKLPTTPSGKIDRKALLKVDIIVESSAQMPERSLTKTQEQVRALWETLFPGRHIALHDDFFAIGGHSLLATQLVFLLRKAFNCDIPLRLLFNHPTLLAMAECIDGYVVSEKGPVDTVDRSFVQDGYERIHWLGGECSTPGLTLLTGATGFLGIYLLRSLLLAGTQSVICLVRARTDKHALARLRENAMRYGIADEIDFSRVEVCLGDIGQRDLGLSPDAYSRLAERVDTVFHAAAQINFLLSYSSVKQSNVQGTLNILAFCGCGGRKTLHYLSTIAVFSPRYPESPIVEHCVPGHPEALSIGYTQSKWVAERYVIQAREQGLDANVFRIGRIGGDSRTGACQSDDFLWRQIKSFIQMGLAPDPSSLSTDLLPVDFVAEAIVALARSEATRQENFHIFHPQSIRFDPVYRAIRSLGYPLETTSDGEWLQQLELCVTQGREVALGPVIHLFKENLLDTGDNAYGNPETTKRITQLGLRFPELSEETFKRMIVYFQRQKEIV	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	255.76	gnl|BL_ORD_ID|4935|hsp_num:0	5928			69	1629	colistin A; colistin B
BGC0000446.1|Tilivalline_18 # 22048 # 22401 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=15bp;gc_cont=0.390	BGC0000446.1|Tilivalline_18 	22048	22401	+	Loose	520	30.0314	OXA-287	38.64	3001742	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGAGAAGTCATCGGATAAGCTGGCATCCCTTTTCTCTGTTAATGGACGTTTGTCGTTGCCTTTCCGTCGCAATAGAGAGGTGATTGTTGGCCGTGAAAATATTCGCTTACACTATGCTAATGGCTTTGGCGTTGCGCCCTTACGCTTTACCTCTATAGAGGATGAACGATTCCACTATACGAATAATCCCGATGTCGTCATTGTTGAATATAAACTACATGGGAATACTCTGCCAGATGGGAAACAGTTCTCTTTGTTATATGTTAATGTGATTGAAATAAATGATGGCAAGATAACTGAATTAATAGATTATGAGGATGTTTTGAACAGAGAATATATCTTTCAGGATTAG	MEKSSDKLASLFSVNGRLSLPFRRNREVIVGRENIRLHYANGFGVAPLRFTSIEDERFHYTNNPDVVIVEYKLHGNTLPDGKQFSLLYVNVIEINDGKITELIDYEDVLNREYIFQD	MSKKLKCLALFTAVFFAIPMTACQSFSQQKQQFSTQKNEQQQISSLFQSAQTSGVLMIYDGKKIQSYGNDLDRAEQRYIPASTFKMLNALIGIQHHKTTPDEVFKWDGKKRAFSSWEKDLTLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPIEEVRFAYALAKQKLPFDQPTQQQVKAMLLVDQIQGTKIYAKSGWGMDVSPQVGWWTGWIEQPNGKITAFSLNMQMSQPEHADARKVIVYQALQELGLLAH	42.09	gnl|BL_ORD_ID|1922|hsp_num:0	3451			426	558	cloxacillin; oxacillin; cefalotin
BGC0000446.1|Tilivalline_19 # 22415 # 22525 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.351	BGC0000446.1|Tilivalline_19 	22415	22525	+	Loose	1000	21.557	mecD	27.59	3004185	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGTTATTAATGGGGGCGAAGGTTATGATAACTTTTCATTCCTTGAAGGGTTATGGTAAAATGGTAAGCTTAACTTATTGTATACGGCATCAGGAGAATGTATGGAAATGA	MLLMGAKVMITFHSLKGYGKMVSLTYCIRHQENVWK	MKNIKVKILIVCSLCLISFFLYNLLKENEIDKIFSSIENRNVDEINENITFLSRNTFSKKQRYDRMNHIDNSLGIKKVNITDIKLLEEIVDTRKYSANMHYDSKFGKFTKKGYFEFEKNGESKRWELNWTPEVIIPGLTATNEVRVEELKSSRGEIVDRNGIPLAIDGEHYQVGIDPKNYNKKDSKQIAKLLNINESTLKNKLKQSWVKDGVFVPIKSYVELSDEIKNKIPEYGLSVNKIKGRTYPLKEASAHLLGYIGEINADELNDPKFKGYDSHSIVGKTGIEYMYDKELQNRDGLIVYITDDDGLTDSKEILVHKKPKNGKKIVLSIDSRVQNSIYNHLKDDNGSGTAMNPKTGELLALVSYPSFNPYDFMFGISNKKYQALLNDKKAPLLNKFQELTSPGSTQKLLTSIIGLNNGVINESKSYEINGKGWRKDGSWGGYKVTRFEVVNGRIDLEKAIAHSDNIFFARTTLEMGGKKFVRGMKDLGVGEETPSDYPVRTGQIANKINLERNLNNDILLADSGYGQGEILVNPIHILSIYSSLVNEGNMMAPKLNMEHKSKVWKKHITSQKNIDILTSSMRKVVTGTHKLDTERNYANFAGKTGTAELKMTQNEGLGTQIGWFVGYDQQNPNMMLAINVKNVEDKGMSSYNAQKFAQVMDDLYEHGARTYEPDSE	5.31	gnl|BL_ORD_ID|2418|hsp_num:0	2828			1614	1701	methicillin
BGC0000446.1|Tilivalline_20 # 22516 # 23013 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=ACG;rbs_spacer=15bp;gc_cont=0.434	BGC0000446.1|Tilivalline_20 	22516	23013	+	Loose	280	41.2022	emrR	25.93	3000516	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAAATGAATAAAAAAGTGGCTAGTGGTTCCGAGCGCGAAATATCATTGAATCGTCAATTTGAAGATGCTTTAGGGAATTTGCAATGCGTACTTGTTGCACGTCGATCGTTGATTAATCCTGATGGTATTAACTGGCCGCAATACGATACGTTGTATATTTTACGTCAGTTCCAGCCGATGACTCCAAGCGCAATTGGTGAAAAGCTCGGATTTGCGCGTAGTAAAATGTCCAAGATCCTGCGGATGTTGAAAGATAAGCACTTTGTTGAGCAGGAGTCGGCAGAAAGCGACAAGCGAGAAATGCTGACGAGGATTACGGAAAAGGGTATTGAATTCCTGAATTCTGCAGAGTCCAGCAGGCGCATAATGGCTGAGCAGGTGGCATCCTGTATGTCGCAGGGAGAGATTGCTATTTTCGCTGAGCTTTGTACAAGGGCTGCCAATATATTACACGAGAATATTAAAGGTAAACTCGAAGATACCAGTGAAAATTAA	MEMNKKVASGSEREISLNRQFEDALGNLQCVLVARRSLINPDGINWPQYDTLYILRQFQPMTPSAIGEKLGFARSKMSKILRMLKDKHFVEQESAESDKREMLTRITEKGIEFLNSAESSRRIMAEQVASCMSQGEIAIFAELCTRAANILHENIKGKLEDTSEN	MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS	93.75	gnl|BL_ORD_ID|1225|hsp_num:0	1330			117	441	nalidixic acid
BGC0000446.1|Tilivalline_21 # 23402 # 23656 # -1 # ID=1_21;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.447	BGC0000446.1|Tilivalline_21 	23402	23656	-	Loose	750	23.8682	tet(52)	50.0	3004587	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	TTGAGCACCTCAGATGCACCCGGTAGCGGGATCATTTCTCTGTACGCAAGAGCTGAATCGATCATTATCAGCAGGGGCAATCATTTACTCGGCTGTCTGTTTTGCGGGGGCAATGAAGGAAGAGAACAAAATGCACCAGTTGCATACCTGCTACTTTCACATTTATTCATCGATATATTGAAAGTAAAGAAATATCTGCTACAGGTATTCGCCAAAACTCCTGTGCTCACCAGACGTAGTGCGAGAATACGCTAA	MSTSDAPGSGIISLYARAESIIISRGNHLLGCLFCGGNEGREQNAPVAYLLLSHLFIDILKVKKYLLQVFAKTPVLTRRSARIR	MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMGIYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRSDLVEILIDSIEGVPLQFNQTIESVKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAYFSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRRVLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQGNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSKEVAEERSNNIMEQVKIASNMIVLQDYANPH	21.54	gnl|BL_ORD_ID|2698|hsp_num:0	3289			60	120	tetracycline; oxytetracycline
BGC0000446.1|Tilivalline_22 # 23741 # 24046 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.461	BGC0000446.1|Tilivalline_22 	23741	24046	-	Loose	200	23.0978	vanT gene in vanE cluster	27.5	3002971	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGTTTGACAAAAGTTTTTTCGCCGCTAAGATACGACTCCACAACGATTCCTCTGTAGTTCAGTCGGTAGAACGGCGGACTGTTAATCCGTATGTCACTGGTTCGAGTCCAGTCAGAGGAGCCAAATTCCTGTTTTCAGCTATCTATGCGAATCTTTTTCAGATATTGATTCAACAGGCTAGCATGGGAACACATCTCGGTGCATTTCTGGTTTTTTCTCCTCCGTGCCGGGAAATGCGGGCACTATCTTTGTTGCGCATAGCATGTCCCACTTCTCCCTTAACAACACGCCAATTGTCAGCCTGA	MFDKSFFAAKIRLHNDSSVVQSVERRTVNPYVTGSSPVRGAKFLFSAIYANLFQILIQQASMGTHLGAFLVFSPPCREMRALSLLRIACPTSPLTTRQLSA	MKHRANGIDLFRIFAATMVVAIHTFPFQSIAPFLDEVITLTVFRVAVPFFFMITGYFLLGRLSLNFSYNNNQRVKKYLYKIGMIYLYSILLYFPLSLLNGTISLKMNILLLLKVFIFDGTFYHLWYFPASIIGTILVTLLLRSIGFKLTVAFSTCLYLVGLGGDSWYGITNQVPLLNKLYTFIFSWSDYTRSGVFFTPVFLCLGIFAYRVSKKLTASKILNLLFYVFIIGMTFESIFLHRFTNVKHDSMYLLLPSCALILFLMLLNWQPKLKVKESADLTLLVYILHPLVIVIVHSISKYIPILKNSLLNFLLVVVCSFILAQLLLNLKRKLRVSKQKIPFERASKEISASAIHHNINEIRKIIPKNTNIMGVVKANAYGCGMVEVAYELEKIGISFFCVATIEEAIALRKSGNQGDILILGYTHPNRINDIKKYNLIQSIVSEEHGKVLNLKKIPIRCHLQVDTGMHRLGVTPNVTIIQQMYLFSNLKIEGIYSHLGSSDSLEQESIARTNTQIFLFNNILSDLEQMGISYGYTHIQSSYGILNYPELSFDFVRIGILCYGFLSDYNSPTKIPIDLQPIVKVKASLITERIVEAGEYVGYGLGAKVEKRTRIGVVSIGYADGIPRALSNAKLTLEFKGQSIKQIGNICMDMMLVDLSEVEDISLNDELIVLPNISKIADEEQTITNELLSRLGSRLGTELN	14.39	gnl|BL_ORD_ID|4680|hsp_num:0	1308			24	144	vancomycin
BGC0000446.1|Tilivalline_24 # 24892 # 25212 # -1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.551	BGC0000446.1|Tilivalline_24 	24892	25212	-	Loose	600	25.409	APH(9)-Ib	36.67	3002663	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(9)	GTGCCACGCCTGACGTTCAGCCTGGCCGATCTGACCTTTTCCGAGACGCCTGCCGGTAATAATTGTCGATGCGGAACCCAGGGCGTTCCCGGGCAGGTTAATCAGCGCAGCCACGGAGAAGGCGATAAAGTTGCCAGCAATCACGTTAGTCCCCATCCCGGCAACGAACATCTGAGTCAGCAGCTTGCCGCCGTTGAACAAAACCGATTCAATGCTGGCGGGAATACCAATGCCCATCACTTCCCAGATAATGGCGAAGTTGAACGGCTTAAAGTAGCTCTTCAGCGAAATGCGCAGCGCCGGGTTAAAGCCGATCATTAA	MPRLTFSLADLTFSETPAGNNCRCGTQGVPGQVNQRSHGEGDKVASNHVSPHPGNEHLSQQLAAVEQNRFNAGGNTNAHHFPDNGEVERLKVALQRNAQRRVKADH	MEDLPENLDQESLFQGLREFGISTTSASYAPLGFGDYHWHITGDDGQRWFATVSDLEHKEHCGHGAPAALRGLRRAMDTAVHLREQGGLPFVVAPRTTSDGASLVPLDSRYALTVFPHVSARPGEFGQKLTERERDQVLVLLAELHGQAPPKCTPTTDMVPTGLDGVHTALAEPSGTWTGGPFSEPARELLAEHEATLRGRMAEFGELVARVRGRGAPLVVTHGEPHPGNLILGEDGYVLVDWDTVGLAIPERDLSLISDDPAALARYTELTGHTPDPAALALYRLRWSLLDVAEFVEWFRGEHQRTSDTEAAWQSFAETLDHLNSEVPS	32.12	gnl|BL_ORD_ID|969|hsp_num:0	1059			615	705	spectinomycin
BGC0000446.1|Tilivalline_26 # 25765 # 25845 # -1 # ID=1_26;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.506	BGC0000446.1|Tilivalline_26 	25765	25845	-	Loose	2070	20.0162	smeE	31.58	3003056	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TCCTCTGACTGGACTCGAACCAGTGACATACGGATTAACAGTCCGCCGTTCTACCGACTGAACTACAGAGGAATCGTTTGA	SSDWTRTSDIRINSPPFYRLNYRGIV	MARFFIDRPIFAWVIAIIIMLAGGLALFKLPVSMYPNVAPPAVEISATYPGASAKVVEDSVTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQEVQRQGINVAKSSSGFLNAIAFVSENGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGGKYAMRIWLDPNKLHTYGLSVPEVTAAIKAQNAQVAIGQLGGAPSVKGQQLNATINAQSRLQTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANALDTAAGVDAALEDMKGFFPAGLKAEIPYDTTPFVRVSIKGVVQTLIEAIVLVFVVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAMLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMALSVLVAIVLTPALCATMLKPLKKGEHHVAHRGLAGRFFNGFNRGFDRTSESYQRGVRGIIHRPWRFMGIVAALFVLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESIAALENHFLQNEKDAVDSVFSVQGFSFAGMGQNAGMAFVKLKDWSERDADNGVMPITGRAMAALGQIKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAGSKKLANVRPNGQEDTPQFRIDIDAAKATSLGLSIDQINGTLAAAWGSSYIDDFVDRGRVKRVFVQADQAFRMVPEDFDLWSVKNDKGEMVPFSAFATKHWDYGSPRLERYNGVSAMEIQGEPAPGVASGDAMAEIEQLAKQLPAGFGIEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAAMYESWSVPTAVLLAAPLGILGAVLANTFKGLERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGASLIESIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGVFFVPLFFVVVQRVFKRRSTT	2.50	gnl|BL_ORD_ID|807|hsp_num:0	876			966	1023	tetracycline; chloramphenicol
